US20050119222A1 - Compositions comprising fermentable fiber which are adapted for use by a companion animal and kits and methods of their use - Google Patents

Compositions comprising fermentable fiber which are adapted for use by a companion animal and kits and methods of their use Download PDF

Info

Publication number
US20050119222A1
US20050119222A1 US10/725,248 US72524803A US2005119222A1 US 20050119222 A1 US20050119222 A1 US 20050119222A1 US 72524803 A US72524803 A US 72524803A US 2005119222 A1 US2005119222 A1 US 2005119222A1
Authority
US
United States
Prior art keywords
composition
companion animal
fiber
fermentable fiber
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/725,248
Inventor
Sharon Norton
Gary Goldy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mars Inc
Procter and Gamble Co
Original Assignee
Iams Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US10/725,248 priority Critical patent/US20050119222A1/en
Application filed by Iams Co filed Critical Iams Co
Assigned to PROCTER & GAMBLE COMPANY, THE reassignment PROCTER & GAMBLE COMPANY, THE ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: NORTON, SHARON ANN, GOLDY, GARY GREGORY
Assigned to PROCTER & GAMBLE COMPANY, THE reassignment PROCTER & GAMBLE COMPANY, THE ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: NORTON, SHARON ANN, GOLDY, GARY GREGORY
Priority to BRPI0417166-7A priority patent/BRPI0417166A/en
Priority to JP2006541496A priority patent/JP2007512024A/en
Priority to AU2004295003A priority patent/AU2004295003B2/en
Priority to CA2547330A priority patent/CA2547330C/en
Priority to PCT/US2004/040084 priority patent/WO2005053425A1/en
Priority to EP04812571.0A priority patent/EP1689247B1/en
Priority to ARP040104488A priority patent/AR046743A1/en
Publication of US20050119222A1 publication Critical patent/US20050119222A1/en
Assigned to THE IAMS COMPANY reassignment THE IAMS COMPANY CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE TO THE IAMS COMPANY PREVIOUSLY RECORDED ON REEL 014531 FRAME 0937. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Assignors: NORTON, SHARON ANN, GOLDY, GARY GREGORY
Assigned to MARS, INCORPORATED reassignment MARS, INCORPORATED ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: THE IAMS COMPANY
Priority to US15/294,503 priority patent/US10681922B2/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K10/00Animal feeding-stuffs
    • A23K10/30Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/142Amino acids; Derivatives thereof
    • A23K20/147Polymeric derivatives, e.g. peptides or proteins
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/163Sugars; Polysaccharides
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K50/00Feeding-stuffs specially adapted for particular animals
    • A23K50/40Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system

Definitions

  • the present invention is directed to compositions comprising a fermentable fiber, wherein the compositions are adapted for use by a companion animal.
  • the invention is further directed to kits comprising such compositions as well as methods of using the compositions and kits.
  • compositions which are useful for enhancing the gastrointestinal health of companion animals.
  • Such compositions may be readily accepted by guardians of companion animals which have not been previously fed high quality companion animal foods, or those which do utilize such high quality foods while still searching for added health benefit for their animal.
  • compositions which comprise at least about 0.25% of total fermentable fiber, by weight of the composition, wherein the composition is a liquid.
  • compositions are provided which comprise a beet pulp or a short chain oligofructose comprising one or more components selected from the group consisting of 1-kestose, nystose, and 1F-beta-fructofuranosylnystose, wherein the composition is a liquid which is adapted for use by a companion animal.
  • Kits comprising such compositions along with information that such compositions are adapted for use by a companion animal, or other information, are also provided. Even further, the present invention provides methods of enhancing the gastrointestinal health or improving the fecal odor of the feces of the of the companion animal comprising orally administering the composition to the companion animal.
  • compositions herein may comprise, consist essentially of, or consist of any of the features or embodiments as described herein.
  • compositions, kits, and methods which are adapted for use by companion animals.
  • “companion animal” means a domestic animal.
  • “companion animal” means a domestic dog, cat, rabbit, ferret, horse, cow, or the like. More preferably, “companion animal” means a domestic dog or cat, particularly a domestic dog.
  • compositions which comprise fermentable fiber, wherein the composition is a liquid.
  • Kits comprising such compositions along with information that such compositions are adapted for use by the companion animal are also provided.
  • the present invention provides methods of enhancing the gastrointestinal health of the companion animal comprising orally administering the composition to the companion animal.
  • compositions herein are adapted for use by a companion animal.
  • the primary use of the compositions described herein is for companion animal use and the compositions are therefore formulated as such.
  • compositions which comprise at least about 0.25% of total fermentable fiber, by weight of the composition, wherein the composition is a liquid.
  • compositions are provided which comprise a short chain oligofructose comprising 1-kestose, nystose, and 1F-beta-fructofuranosylnystose, wherein the composition is a liquid.
  • the compositions are adapted for use by a companion animal.
  • Fermentable fibers provide an important role in the gastrointestinal health of companion animals.
  • High quality companion animal foods such as certain foods commercially marketed as IAMS or EUKANUBA foods (The lams Company, Dayton, Ohio, U.S.A.) provide fermentable fibers as a component of daily kibble diet.
  • many commercially available companion animal foods are devoid of such components, which can compromise the gastrointestinal health, or optimization of the gastrointestinal health, of the companion animal.
  • commercially available gravies or other aqueous supplements fail to provide such fermentable fibers, particularly at meaningful levels for efficacious treatment of the companion animal.
  • gravies which are provided to supplement the nutritional benefits of daily animal feed fail to provide the important elements for sound gastrointestinal health.
  • the present inventors have advantageously discovered that the compositions adapted for use by companion animals are particularly suited for supplementing these needs.
  • the present compositions may be used to supplement diets which are already of high quality, or to supplement compromised diets.
  • the fermentable fiber may be any fiber source which intestinal bacteria present in the animal can ferment to produce short chain fatty acids or other metabolic components.
  • Non-limiting examples of such fermentable fibers include beet pulp (from sugar beet), gum arabic, gum talha, psyllium, rice bran, carob bean gum, citrus pulp, pectin, fructooligosaccharide, mannanoligofructose, soy fiber, arabinogalactan, galactooligosaccharide, arabinoxylan, and mixtures thereof.
  • fermentable fibers are not digested by mammals but may be metabolized by intestinal bacterial species, such as Bifidobacterium .
  • intestinal bacteria such as Bifidobacterium
  • bacteria such as Salmonella, E. coli and Clostridia are unable to process such fiber to any meaningful degree.
  • This preferential digestibility which is applicable for fermentable fiber as a class, can be used to improve the overall bacterial flora in the small intestine of the companion animal.
  • fermentable fibers will only feed “good” bacteria such as Lactobacillus and Bifidobacterium , the amounts of harmful bacteria such as Salmonella, E. coli and Clostridia may decrease due to a reduction in food resources. Therefore, by providing a preferred food source for beneficial bacterial species, a diet supplemented with fermentable fiber can increase “good” intestinal bacteria while reducing the amount of “bad” bacteria.
  • fructooligosaccharides are naturally occurring compounds which can be found in a variety of fruits or vegetables including banana, barley, garlic, honey, onion, rye, brown sugar, tomato, asparagus, artichoke, wheat, yacon, or chicory.
  • Fructooligosaccharide may for example be provided as chicory root, as a long chain oligofructose (e.g., inulin), or as short chain oligofructose.
  • fructooligosaccharide comprising at least one of 1-kestose (abbreviated as GF 2 ), nystose (GF 3 ), and 1F-beta-fructofuranosylnystose (GF 4 ). While fructooligosaccharides can be extracted from plants such as those mentioned herein, they can also be formed artificially by adding one, two, or three fructose units to a sucrose molecule by a B-(2-1)-glycosidic linkage of the fructose unit(s) to the fructose unit of sucrose.
  • 1-kestose abbreviated as GF 2
  • GF 3 nystose
  • GF 4 1F-beta-fructofuranosylnystose
  • fructooligosaccharides are commercially available under the tradename NUTRAFLORA from Golden Technologies Company, Incorporated (which is a short chain oligofructose comprising 1-kestose, nystose, and 1F-beta-fructofuranosylnystose.
  • NUTRAFLORA a short chain oligofructose comprising 1-kestose, nystose, and 1F-beta-fructofuranosylnystose.
  • a mixture of short chain fructooligosaccharide and inulin can be PREBIO1 or a mixture of commercially available RAFTILOSE and RAFTILINE.
  • the fructooligosaccharide may be a short chain oligofructose, which will be well-known to those of ordinary skill in the art. Particularly useful herein are short chain oligofructose comprising 1-kestose (abbreviated as GF 2 ), nystose (GF 3 ), and 1F-beta-fructofuranosylnystose (GF 4 ).
  • GF 2 1-kestose
  • GF 3 nystose
  • GF 4 1F-beta-fructofuranosylnystose
  • the short chain oligofructose comprises from about 25% to about 45% 1-kestose, from about 25% to about 45% nystose, and from about 1% to about 20% 1F-beta-fructofuranosylnystose, by weight of the short chain oligofructose, alternatively from about 30% to about 40% 1-kestose, from about 50% to about 60% nystose, and from about 5% to about 15% 1F-beta-fructofuranosylnystose, by weight of the short chain oligofructose.
  • short chain oligofructose is commercially available under the tradename NUTRAFLORA from Golden Technologies Company, Incorporated (which is a short chain oligofructose comprising about 35% 1-kestose, 55% nystose, and 10% 1F-beta-fructofuranosylnystose, all by weight of the short chain oligofructose).
  • the fermentable fibers may display certain organic matter disappearance percentages.
  • the fermentable fibers may have an organic matter disappearance (OMD) of from about 15% to about 60% when fermented by fecal bacteria in vitro over a 24 hour period. That is, from about 15% to about 50% of the total organic matter originally present is fermented and converted by the fecal bacteria.
  • OMD organic matter disappearance
  • the organic matter disappearance of the fibers is alternatively from about 20% to about 50%, alternatively from about 30% to about 40%.
  • in vitro OMD percentage may be calculated as follows: (1 ⁇ (( OM residue ⁇ OM blank)/original OM )) ⁇ 100 where OM residue is the organic matter recovered after 24 hours of fermentation, OM blank is the organic matter recovered in corresponding blank tubes (i.e., tubes containing medium and diluted feces, but no substrate), and original OM is that organic matter placed into the tube prior to fermentation. Additional details of the procedure are found in Sunvold et al., J. Anim. Sci., Vol. 73, pp. 1099-1109 (1995).
  • the compositions comprise at least about 0.25% total fermentable fiber, by weight of the composition.
  • total fermentable fiber it is meant that the referenced level is determined by adding the relative amounts of each fermentable fiber present in the composition. For example, wherein a composition comprises 1% fructooligosaccharide and 0.5% beet pulp, by weight of the composition, and no other fermentable fiber, the composition comprises 1.5% total fermentable fiber, by weight of the composition.
  • the present compositions comprise at least about 0.5% total fermentable fiber, at least about 1% total fermentable fiber, at least about 2% total fermentable fiber, alternatively from about 1% to about 20% total fermentable fiber, alternatively from about 1% to about 10% total fermentable fiber, alternatively from about 2% to about 10% total fermentable fiber, or alternatively from about 3% to about 8% total fermentable fiber, all by weight of the composition.
  • short chain oligofructose is utilized, it has been surprisingly discovered that, optionally, at least about 0.05% of the short chain oligofructose may be utilized, alternatively from about 0.1% to about 20%, alternatively from about 0.1% to about 10%, alternatively from about 0.1% to about 8%, alternatively from about 0.15% to about 5%, all by weight of the composition.
  • compositions herein are liquids; as used herein, the term “liquid” is as will be commonly understood in the art, with the understanding that the composition may contain solid particulates or other solid matter while still maintaining the overall liquid character of the composition.
  • Liquids are typically flowable at ambient temperature.
  • the compositions are typically intended for use by companion animals as a supplement to ordinary dietetic needs. As such, these compositions are advantageously provided as drinking waters, gravies, or other supplements. Drinking waters may be fully or partially substituted for ordinary drinking water provided to the companion animal, or may even be in contact with, or admixed with, companion animal food.
  • Gravies, as described herein, are broadly defined. Gravies may be any gravy, topping, sauce, or other liquid mixture. Gravies may have a viscosity which is greater than distilled water at ambient temperature. Gravies may be orally administered directly to the companion animal, but are advantageously contacted or admixed with food prior to oral administration.
  • compositions may optionally comprise at least about 50% water, by weight of the composition.
  • the compositions comprise at least about 60% water, at least about 70% water, at least about 80% water, from about 50% to about 99% water, from about 60% to about 97% water, from about 70% to about 95% water, or from about 75% to about 90% water, all by weight of the composition.
  • the water included at these levels includes all added water and any water present in combination components, for example, broths.
  • compositions herein may comprise additional optional components to enhance, for example, their performance in providing gastrointestinal health, other health benefits, a desirable nutritional profile, and/or organoleptic properties.
  • optional components may be dispersed, solubilized, or otherwise mixed into the present compositions.
  • Non-limiting examples of optional components suitable for use herein are given below.
  • animal meats such as chicken, pork, beef, veal, fish, and the like may be utilized.
  • animal meats are in particle or chunk form, such that the composition maintains an overall liquid form, such as spray-dried animal meats. Broths and fats of any animal meats may be used.
  • the meats, broths, or fats mentioned herein may also be utilized as a flavor to enhance palatability of the composition.
  • one or more other flavors may additionally or alternatively be utilized. Any natural or synthetic flavor can be used in the present invention.
  • Flavors may be those which are meat flavors, for example, by utilizing a meat source or a flavor which simulates a meat flavor.
  • yeast may be utilized to simulate chicken flavor as desired.
  • Other natural or synthetic meat extracts may be used.
  • vegetable flavors or flavors which simulate the properties of vegetable flavors may be utilized.
  • the flavor agent can also comprise a blend of various flavors. If desired, the flavor in the flavoring agent may be formed into emulsion droplets which are then dispersed in the composition.
  • the flavoring agents are conventionally available as concentrates or extracts or in the form of synthetically produced flavoring esters, alcohols, aldehydes, terpenes, sesquiterpenes, and the like.
  • the present compositions may have any pH, provided that the composition is adapted for use, particularly ingestion, by a companion animal.
  • the present compositions have a pH of less than about 7, less than about 6, less than about 5, less than about 4, less than about 3.5, from about 2 to about 7, from about 2.5 to about 5, from about 2.5 to about 4, or from about 2.5 to about 3.5.
  • Those compositions having a pH of less than about 3.5 are particularly preferred, as these compositions may not require refrigeration upon exposure to air such to provide shelf-stability over time and may not require aseptic packaging processes.
  • the present compositions may comprise one or more acidulants in order to reach, and maintain, the desired pH. Acidity can be adjusted to and maintained within the requisite range by known and conventional methods, e.g., the use of one or more acidulants.
  • Organic as well as inorganic edible acids may be used to adjust the pH of the compositions.
  • the acids can be present in their undissociated form or, alternatively, as their respective salts, for example, potassium or sodium hydrogen phosphate, potassium or sodium dihydrogen phosphate salts.
  • Illustrative acids are edible organic acids which include citric acid, malic acid, fumaric acid, adipic acid, phosphoric acid, gluconic acid, tartaric acid, ascorbic acid, acetic acid, phosphoric acid or mixtures thereof.
  • compositions may comprise from about 0.01% to about 5% edible acid, from about 0.1% to about 4% edible acid, from about 0.5% to about 3% edible acid, or from about 0.7% to about 2% edible acid, all by weight of the composition.
  • omega-3-fatty acids may be added to the present compositions.
  • the omega-3-fatty acid optionally utilized herein may be any omega-3-fatty acid or combination of omega-3-fatty acids.
  • Non-limiting examples of omega-3-fatty acids which are suitable for use herein include eicosapentaenoic acid (also known as EPA), docosahexaenoic acid (also known as DHA), and mixtures thereof.
  • Omega-3-fatty acids are often sourced from marine (fish) sources, including menhaden (a herring-like fish), or other sources such as flax.
  • compositions herein may optionally, but preferably, be fortified further with one or more nutrients, especially one or more vitamins and/or minerals.
  • vitamins and minerals include niacin, thiamin, folic acid, pantothenic acid, biotin, vitamin A (including vitamin A (retinol), ⁇ -carotene, retinol palmitate, or retinol acetate), vitamin C, vitamin B 2 , vitamin B 3 , vitamin B 6 , vitamin B 12 , vitamin D, vitamin E, vitamin K, iron, zinc, copper, phosphorous, iodine, chromium, molybdenum, fluoride, calcium, manganese, magnesium, or boron.
  • vitamins and minerals include niacin, thiamin, folic acid, pantothenic acid, biotin, vitamin A (including vitamin A (retinol), ⁇ -carotene, retinol palmitate, or retinol acetate), vitamin C, vitamin B
  • preservatives may additionally be utilized herein.
  • Preferred preservatives include, for example, sorbate, benzoate, and polyphosphate preservatives. Preservatives may be avoided wherein the pH is manipulated to levels which are less than about 3.5.
  • compositions according to the present invention may optionally further comprise one or more thickeners, including xanthan gum, carboxymethylcellulose, carboxyethylcellulose, hydroxypropylcellulose, methylcellulose, microcrystalline cellulose, starches, dextrins, fermented whey, tofu, maltodextrins, propylene glycol alginate, gellan gum, guar gum, pectin, tragacanth gum, gum acacia, locust bean gum, gum arabic, gelatin, as well as mixtures of these thickeners. Some of these thickeners may also be utilized as a fermentable fiber source.
  • thickeners including xanthan gum, carboxymethylcellulose, carboxyethylcellulose, hydroxypropylcellulose, methylcellulose, microcrystalline cellulose, starches, dextrins, fermented whey, tofu, maltodextrins, propylene glycol alginate, gellan gum, guar gum, pectin,
  • One or more emulsifiers and/or oils may also be included in the present compositions for texture and opacity purposes.
  • Typical emulsifiers and oils useful herein include, for example, mono-di glycerides, lecithin, pulp, cottonseed oil, and vegetable oil.
  • one or more vegetables may be included in the present compositions.
  • examples of such vegetables include celery, potato, tomato, pea, carrot, and the like.
  • Vegetables may be dehydrated vegetables which are minced, diced, or otherwise prepared such that the particle size is controlled as desired.
  • kits comprising the foregoing compositions and information, such that the consumer (including companion animal guardian, breeder, veterinarian, or the like) will readily comprehend benefits of the present compositions.
  • the kits comprise:
  • kits of the present invention may comprise one or more compositions together with information which informs a user of the kit, by words, pictures, and/or the like, that use of the kit is useful for enhancement of gastrointestinal health of the companion animal, or that the composition is adapted for use by a companion animal.
  • information need not utilize the actual terms used herein, for example, “gastrointestinal”, “companion”, or “adapted for use”, but rather use of words or terms, pictures, symbols, and the like conveying the same or similar meaning are contemplated within the scope of this invention.
  • the information is printed on a container holding the composition, e.g., a bottle.
  • kits may be in the form of one bottle containing the composition, or may be obtained as a plurality of bottles each containing the composition.
  • the kits may be obtained as one bottle, or cases of four, six, seven or eight bottles co-packaged together.
  • Each container may hold a variety of quantities of composition; for example, the container may contain a single dose or multiple doses of the composition.
  • the methods of the present invention comprise orally administering (i.e., through ingestion) a composition of the present invention to a companion animal to provide improvement in gastrointestinal health and/or improvement in the fecal odor of the feces of the companion animal, as applicable.
  • the enhancement of gastrointestinal health may include any one or more of the following benefits: therapeutically relieving the symptoms of, or prevention of, gastrointestinal inflammatory disorders, inflammatory bowel disease, diarrhea or loose stools; otherwise improving fecal quality; weight loss associated with diarrhea or loose stools; treatment of small intestine bacterial overgrowth; or manipulation of levels of bacteria including improving levels of beneficial bacteria relative to harmful bacteria and/or decreasing pathogenic bacteria.
  • ancillary benefits to improvement in the fecal odor of the feces of the companion animal include removal of putrefactive substances which are known to promote, either directly or indirectly, carcinogenic effects in the mammalian system. Therefore, reducing pro-carcinogenic substances or effects, specifically reducing risk of cancer, is a useful benefit herein.
  • Various methods of analysis directed to these benefits are described herein below.
  • compositions of the present invention are most preferably ingested by companion animals.
  • the compositions may be ingested as a supplement to normal dietetic requirements.
  • the term “orally administering” with respect to the companion animal means that the animal ingests or a human is directed to feed, or does feed, the animal one or more compositions herein. Wherein the human is directed to feed the composition, such direction may be that which instructs and/or informs the human that use of the composition may and/or will provide the referenced benefit, for example, an enhanced gastrointestinal health benefit.
  • such direction may be oral direction (e.g., through oral instruction from, for example, a veterinarian or other health professional), radio or television media (i.e., advertisement), or written direction (e.g., through written direction from, for example, a veterinarian or other health professional (e.g., scripts), sales professional or organization (e.g., through, for example, marketing brochures, pamphlets, or other instructive paraphernalia), written media (e.g., internet, electronic mail, or other computer-related media)), and/or packaging associated with the composition (e.g., a label present on a container holding the composition).
  • written means through words, pictures, symbols, and/or other visible descriptors. Such information need not utilize the actual words used herein, for example, “gastrointestinal”, “companion”, or “adapted for use”, but rather use of words, pictures, symbols, and the like conveying the same or similar meaning are contemplated within the scope of this invention.
  • compositions described herein may be used as a supplement to ordinary dietetic requirements, or may be nutritionally balanced for those companion animals which have difficulty ingesting solid foods. Administration may be on an as-needed or as-desired basis, for example, once-monthly, once-weekly, or daily (including multiple times daily, or with each feeding).
  • the composition When utilized as a supplement to ordinary dietetic requirements, the composition may be administered directly to the companion animal or otherwise contacted with or admixed with companion animal food.
  • the amount of composition utilized may be dependent on a variety of factors, including the quality of gastrointestinal health of the animal, preference of the animal as determined by the guardian of the animal or other person administering the composition, the quality of the companion animal food, and size or breed or the companion animal.
  • compositions may be utilized to enhance the gastrointestinal health of the companion animal or improve fecal odor of the feces of the companion animal.
  • Various methods of demonstrating such enhancements or improvements are well-known to those of ordinary skill in the art. As examples, the following provides illustrations of certain methods which may be used. These methods are not intended to limit the scope of the invention.
  • compositions herein may be measured by their ability to reduce the amount of harmful bacteria in the small intestine (also referenced as treating small intestinal bacterial overgrowth, or IBO). Such methods are described in Reinhart, U.S. Pat. No. 5,776,524 (1998).
  • fecal matter quality may also be indicative of gastrointestinal health.
  • the treatment or prevention of gastrointestinal infection, including diarrhoea, in companion animals may be measured using stool scores. Stools scores may be recorded daily according to the following guidelines and control and test groups compared before and after administering the compositions according to the present invention.
  • This stool is hard and does not stick to surfaces. Stool will roll when pushed. No indentations are made when stool is picked up. Stool is often defecated in groups of individual stools instead of one complete unit. The stool maintains original shape after collection.
  • This stool is firm, well shaped, and cylindrical. This stool does not break apart easily when picked up. This stool may leave residue on surfaces and gloves. This stool is often defecated as one unit. The stool maintains original shape after collection.
  • This stool is soft, however there are definite shapes. This stool will break apart easily and will definitely leave residue on surfaces and gloves. The stool often loses original shape after collection. This stool is often present with another score but can comprise whole stool sample.
  • This stool is soft and will have no cylindrical shape.
  • the shape often associated with a “2” is a “cow patty” shape.
  • This stool will lose the original shape when collected and will definitely leave residue on surfaces and gloves.
  • This stool score is often present with another score but can comprise the whole stool sample. This stool sample may spread over an area of several inches.
  • This stool score will always resemble liquid and there may or may not be particulate matter present. This stool will often be defecated in groups of piles instead of one complete unit. Mucous is often present with this stool sample. This stool sample is very difficult to collect and residue is always left on surfaces and gloves. This stool sample may spread over an area of several inches.
  • the enhancement of gastrointestinal health in companion animals may comprise improving microbial ecology of companion animals.
  • Improving the microbial ecology of companion animals preferably comprises reducing the levels of pathogenic bacteria in the feces of companion animals.
  • the levels of pathogenic bacteria present in the feces of companion animals may be enumerated using the standard plate count method known to those skilled in the art.
  • the pathogenic bacteria are selected from the group consisting of Clostridia, Escherichia, Salmonella, Bacteriodes and mixtures thereof.
  • suitable strains of pathogenic bacteria include B. fragilis, C. perfringens, C. difficile, Eschericia coli, Salmonella typhimurium and mixtures thereof.
  • Improvement of Fecal Odor of the Feces of a Companion Animal Methods of measuring improvement of fecal odor of the feces of a companion animal will be well-known to those having ordinary skill in the art. An illustrative example of making such measurements is set forth in U.S. Pat. No. 5,952,033, which generally instructs as follows: A trial is conduct using a defined number of dogs. The control food is provided, wherein the control food is a commercially available dry dog food (which is nutritionally balanced) which is devoid of short chain oligofructose.
  • a test food which corresponds to the control food except that it includes from about 0.01% to about 0.2% of short chain oligofructose, by weight of the food, as described herein.
  • Half of the dogs are fed the control food and the remaining half are fed the test food.
  • Fecal samples are collected from each dog, heated for 2 hours at 30° C., and the compounds released are trapped on a Tenax tube, or equivalent. The trapped compounds are desorbed on a gas chromatograph. The levels of dimethylsulfide, dimethldisulfide, and dimethyltrisulfide are determined for each of the control and test foods.
  • test food results in improved fecal odor relative to administration of the control food, as measured by decreases in the levels of dimethylsulfide, dimethldisulfide, and dimethyltrisulfide, which are believed to cause unpleasant odor.
  • compositions of the present invention are made according to methods which will be well known by the ordinarily skilled artisan.
  • the compositions of the present invention may be prepared by dissolving, dispersing, or otherwise mixing all components singularly or in suitable combinations together, and in water where appropriate, agitating with a mechanical stirrer until all of the ingredients have been solubilized or adequately dispersed.
  • a beef-flavor gravy composition is prepared by combining the following components in a conventional manner: Component Wt % Fructooligosaccharide 5.3 Chicken Fat 3.0 Spray-Dried Beef Particles and Broth 3.0 Xanthan Gum 0.5 Flax Seed 0.2 Vegetables 0.2 Vitamins 0.06 Minerals 0.04 Phosphoric Acid 0.95 Beef Flavor 0.1 Water Remainder
  • One fluid ounce of the gravy composition is admixed with one-half cup of standard dog kibble diet daily prior to feeding to a dog. Amounts of the gravy composition are determined as desired by the guardian of the dog.
  • a chicken-flavor gravy composition is prepared by combining the following components in a conventional manner: Component Wt % Short Chain Oligofructose (NUTRAFLORA, 5.3 commercially available from GTC Nutrition, Golden, CO., U.S.A.) Chicken Fat 3.0 Spray-Dried Chicken Particles and Broth 3.0 Beet Pulp 0.4 Xanthan Gum 0.5 Flax Seed 0.15 Vegetables 0.2 Vitamins 0.06 Minerals 0.04 Phosphoric Acid 0.95 Chicken Flavor 0.53 Water Remainder
  • Two fluid ounces of the gravy composition is admixed with one-half cup of standard dog kibble diet daily prior to feeding to a dog.
  • the following illustrates how to use the present compositions.
  • Twenty-four dogs having intestinal bacterial overgrowth are used to determine the effects of the composition according to Example 1 on the dog gastrointestinal system.
  • the dogs are of age ranging from 12 months to 24 months old.
  • the dogs are fed an initial diet (Diet A) for two months.
  • Diet A contains no fermentable fiber, but each feeding contains 10 ounces of kibble containing chicken by-product meal, corn, chicken fat, rice, Brewers yeast, egg, nutrients, and corn starch, which is admixed with 2 ounces of a gravy in accordance with Example 1 except that water substitutes for the fructooligosaccharide and beet pulp.
  • Intestinal juice and mucosal tissue from the dogs is sampled and cultured at conclusion of feeding Diet A. Twenty-eight days afterwards, the dogs are fed Diet B, which is same kibble utilized in Diet A but mixed with the composition according to Example 1. Intestinal juice, mucosal tissue, and fresh fecal samples are re-sampled 6 weeks after starting Diet B. The intestinal juice and mucosal tissue are sampled for aerobic and anaerobic bacteria. The dogs ingesting Diet B show significantly fewer aerobic and anaerobic bacteria in the intestinal juice and mucosa, and remediical ( Bifidobacteria, Lactobacilli, Eubacteria ) and pathogenic ( B. fragilis, C. perfringens, C. difficile, Eschericia coli ) in the intestinal juice, mucosa, and fecal samples relative to sampling occurring upon ingestion of Diet A.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Animal Husbandry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Physiology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Botany (AREA)
  • Birds (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Fodder In General (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The present disclosure is directed to compositions, kits, and methods which are adapted for use by companion animals. In one embodiment, compositions are provided which comprise a fermentable fiber, wherein the composition is a liquid and is adapted for use by a companion animal. Kits comprising such compositions along with information that such compositions are adapted for use by a companion animal are also provided. Even further, the disclosure describes methods of enhancing the gastrointestinal health of the companion animal comprising orally administering the composition to the companion animal.

Description

    FIELD OF THE INVENTION
  • The present invention is directed to compositions comprising a fermentable fiber, wherein the compositions are adapted for use by a companion animal. The invention is further directed to kits comprising such compositions as well as methods of using the compositions and kits.
  • BACKGROUND OF THE INVENTION
  • Gastrointestinal health is a consistent concern among guardians of companion animals, including breeders and veterinarians. Stomach upset, refusal to ingest food, diarrhea, and the like can be distressing for the guardian and companion animal alike. Many currently available pet foods contain components which serve to enhance gastrointestinal health, however, it is recognized that not all guardians of companion animals choose to make these higher quality foods available to their companion animals. Rather, many guardians are attracted to purchasing lower quality foods with the mindset that their companion animal will more readily enjoy the taste or appearance of such food.
  • Still further, many traditional forms of companion animal food are not completely consumed by the companion animal. As such, the animal may be lacking in basic nutritional requirements.
  • It is therefore necessary to seek developments which encourage guardians of companion animals to provide supplements to the ordinary dietetic intake of the companion animal. Most recently, supplements such as gravies have been introduced to the marketplace. Many such supplements provide a wide variety of vitamins and minerals, as well as palatability aids such as animal meats and fats.
  • The present inventors provide herein compositions which are useful for enhancing the gastrointestinal health of companion animals. Such compositions may be readily accepted by guardians of companion animals which have not been previously fed high quality companion animal foods, or those which do utilize such high quality foods while still searching for added health benefit for their animal.
  • SUMMARY OF THE INVENTION
  • The present invention is directed to compositions, kits, and methods which are adapted for use by companion animals. In one embodiment of the present invention, compositions are provided which comprise at least about 0.25% of total fermentable fiber, by weight of the composition, wherein the composition is a liquid. In another embodiment herein, compositions are provided which comprise a beet pulp or a short chain oligofructose comprising one or more components selected from the group consisting of 1-kestose, nystose, and 1F-beta-fructofuranosylnystose, wherein the composition is a liquid which is adapted for use by a companion animal.
  • Kits comprising such compositions along with information that such compositions are adapted for use by a companion animal, or other information, are also provided. Even further, the present invention provides methods of enhancing the gastrointestinal health or improving the fecal odor of the feces of the of the companion animal comprising orally administering the composition to the companion animal.
  • DETAILED DESCRIPTION OF THE INVENTION
  • Various documents including, for example, publications and patents, are recited throughout this disclosure. All such documents are hereby incorporated by reference. The citation of any given document is not to be construed as an admission that it is prior art with respect to the present invention.
  • All percentages and ratios are calculated by weight unless otherwise indicated. All percentages and ratios are calculated based on the total composition unless otherwise indicated.
  • Referenced herein are trade names for components including various ingredients utilized in the present invention. The inventors herein do not intend to be limited by materials under a certain trade name. Equivalent materials (e.g., those obtained from a different source under a different name or reference number) to those referenced by trade name may be substituted and utilized in the descriptions herein.
  • In the description of the invention various embodiments or individual features are disclosed. As will be apparent to the ordinarily skilled practitioner, all combinations of such embodiments and features are possible and can result in preferred executions of the present invention.
  • The compositions herein may comprise, consist essentially of, or consist of any of the features or embodiments as described herein.
  • While various embodiments and individual features of the present invention have been illustrated and described, various other changes and modifications can be made without departing from the spirit and scope of the invention. As will also be apparent, all combinations of the embodiments and features taught in the foregoing disclosure are possible and can result in preferred executions of the invention.
  • The present invention is directed to compositions, kits, and methods which are adapted for use by companion animals. As used herein, “companion animal” means a domestic animal. Preferably, “companion animal” means a domestic dog, cat, rabbit, ferret, horse, cow, or the like. More preferably, “companion animal” means a domestic dog or cat, particularly a domestic dog.
  • In one embodiment of the present invention, compositions are provided which comprise fermentable fiber, wherein the composition is a liquid. Kits comprising such compositions along with information that such compositions are adapted for use by the companion animal are also provided. Even further, the present invention provides methods of enhancing the gastrointestinal health of the companion animal comprising orally administering the composition to the companion animal.
  • The Compositions of the Present Invention
  • The compositions herein are adapted for use by a companion animal. In this respect, as will be well-understood by the ordinarily skilled artisan, the primary use of the compositions described herein is for companion animal use and the compositions are therefore formulated as such.
  • As described herein, in one embodiment, compositions are provided which comprise at least about 0.25% of total fermentable fiber, by weight of the composition, wherein the composition is a liquid. In another embodiment herein, compositions are provided which comprise a short chain oligofructose comprising 1-kestose, nystose, and 1F-beta-fructofuranosylnystose, wherein the composition is a liquid. The compositions are adapted for use by a companion animal.
  • Fermentable fibers provide an important role in the gastrointestinal health of companion animals. High quality companion animal foods, such as certain foods commercially marketed as IAMS or EUKANUBA foods (The lams Company, Dayton, Ohio, U.S.A.) provide fermentable fibers as a component of daily kibble diet. However, many commercially available companion animal foods are devoid of such components, which can compromise the gastrointestinal health, or optimization of the gastrointestinal health, of the companion animal. Even further, commercially available gravies or other aqueous supplements fail to provide such fermentable fibers, particularly at meaningful levels for efficacious treatment of the companion animal. As such, gravies which are provided to supplement the nutritional benefits of daily animal feed fail to provide the important elements for sound gastrointestinal health. The present inventors have advantageously discovered that the compositions adapted for use by companion animals are particularly suited for supplementing these needs. As an example, the present compositions may be used to supplement diets which are already of high quality, or to supplement compromised diets.
  • Fermentable fibers are well-known in the art. The fermentable fiber may be any fiber source which intestinal bacteria present in the animal can ferment to produce short chain fatty acids or other metabolic components. Non-limiting examples of such fermentable fibers include beet pulp (from sugar beet), gum arabic, gum talha, psyllium, rice bran, carob bean gum, citrus pulp, pectin, fructooligosaccharide, mannanoligofructose, soy fiber, arabinogalactan, galactooligosaccharide, arabinoxylan, and mixtures thereof.
  • In general, fermentable fibers are not digested by mammals but may be metabolized by intestinal bacterial species, such as Bifidobacterium. However, not all intestinal bacteria can metabolize fermentable fiber. In particular, bacteria such as Salmonella, E. coli and Clostridia are unable to process such fiber to any meaningful degree. This preferential digestibility, which is applicable for fermentable fiber as a class, can be used to improve the overall bacterial flora in the small intestine of the companion animal. Because fermentable fibers will only feed “good” bacteria such as Lactobacillus and Bifidobacterium, the amounts of harmful bacteria such as Salmonella, E. coli and Clostridia may decrease due to a reduction in food resources. Therefore, by providing a preferred food source for beneficial bacterial species, a diet supplemented with fermentable fiber can increase “good” intestinal bacteria while reducing the amount of “bad” bacteria.
  • Beet pulp and fructooligosaccharide, particularly short chain oligofructose, are particularly preferred fermentable fibers for use herein. As an example, fructooliogosaccharides are naturally occurring compounds which can be found in a variety of fruits or vegetables including banana, barley, garlic, honey, onion, rye, brown sugar, tomato, asparagus, artichoke, wheat, yacon, or chicory. Fructooligosaccharide may for example be provided as chicory root, as a long chain oligofructose (e.g., inulin), or as short chain oligofructose. Particularly useful herein are fructooligosaccharide comprising at least one of 1-kestose (abbreviated as GF2), nystose (GF3), and 1F-beta-fructofuranosylnystose (GF4). While fructooligosaccharides can be extracted from plants such as those mentioned herein, they can also be formed artificially by adding one, two, or three fructose units to a sucrose molecule by a B-(2-1)-glycosidic linkage of the fructose unit(s) to the fructose unit of sucrose. As an example, fructooligosaccharides are commercially available under the tradename NUTRAFLORA from Golden Technologies Company, Incorporated (which is a short chain oligofructose comprising 1-kestose, nystose, and 1F-beta-fructofuranosylnystose. As another example, a mixture of short chain fructooligosaccharide and inulin can be PREBIO1 or a mixture of commercially available RAFTILOSE and RAFTILINE.
  • The fructooligosaccharide may be a short chain oligofructose, which will be well-known to those of ordinary skill in the art. Particularly useful herein are short chain oligofructose comprising 1-kestose (abbreviated as GF2), nystose (GF3), and 1F-beta-fructofuranosylnystose (GF4). In a preferred embodiment, the short chain oligofructose comprises from about 25% to about 45% 1-kestose, from about 25% to about 45% nystose, and from about 1% to about 20% 1F-beta-fructofuranosylnystose, by weight of the short chain oligofructose, alternatively from about 30% to about 40% 1-kestose, from about 50% to about 60% nystose, and from about 5% to about 15% 1F-beta-fructofuranosylnystose, by weight of the short chain oligofructose. As an example, short chain oligofructose is commercially available under the tradename NUTRAFLORA from Golden Technologies Company, Incorporated (which is a short chain oligofructose comprising about 35% 1-kestose, 55% nystose, and 10% 1F-beta-fructofuranosylnystose, all by weight of the short chain oligofructose).
  • In an embodiment herein, the fermentable fibers may display certain organic matter disappearance percentages. In this optional embodiment, the fermentable fibers may have an organic matter disappearance (OMD) of from about 15% to about 60% when fermented by fecal bacteria in vitro over a 24 hour period. That is, from about 15% to about 50% of the total organic matter originally present is fermented and converted by the fecal bacteria. The organic matter disappearance of the fibers is alternatively from about 20% to about 50%, alternatively from about 30% to about 40%.
  • Thus, in vitro OMD percentage may be calculated as follows:
    (1−((OM residue−OM blank)/original OM))×100
    where OM residue is the organic matter recovered after 24 hours of fermentation, OM blank is the organic matter recovered in corresponding blank tubes (i.e., tubes containing medium and diluted feces, but no substrate), and original OM is that organic matter placed into the tube prior to fermentation. Additional details of the procedure are found in Sunvold et al., J. Anim. Sci., Vol. 73, pp. 1099-1109 (1995).
  • In one embodiment herein, the compositions comprise at least about 0.25% total fermentable fiber, by weight of the composition. By “total fermentable fiber” it is meant that the referenced level is determined by adding the relative amounts of each fermentable fiber present in the composition. For example, wherein a composition comprises 1% fructooligosaccharide and 0.5% beet pulp, by weight of the composition, and no other fermentable fiber, the composition comprises 1.5% total fermentable fiber, by weight of the composition. Alternatively, the present compositions comprise at least about 0.5% total fermentable fiber, at least about 1% total fermentable fiber, at least about 2% total fermentable fiber, alternatively from about 1% to about 20% total fermentable fiber, alternatively from about 1% to about 10% total fermentable fiber, alternatively from about 2% to about 10% total fermentable fiber, or alternatively from about 3% to about 8% total fermentable fiber, all by weight of the composition.
  • Alternatively or additionally, wherein short chain oligofructose is utilized, it has been surprisingly discovered that, optionally, at least about 0.05% of the short chain oligofructose may be utilized, alternatively from about 0.1% to about 20%, alternatively from about 0.1% to about 10%, alternatively from about 0.1% to about 8%, alternatively from about 0.15% to about 5%, all by weight of the composition.
  • The compositions herein are liquids; as used herein, the term “liquid” is as will be commonly understood in the art, with the understanding that the composition may contain solid particulates or other solid matter while still maintaining the overall liquid character of the composition. Liquids are typically flowable at ambient temperature. The compositions are typically intended for use by companion animals as a supplement to ordinary dietetic needs. As such, these compositions are advantageously provided as drinking waters, gravies, or other supplements. Drinking waters may be fully or partially substituted for ordinary drinking water provided to the companion animal, or may even be in contact with, or admixed with, companion animal food. Gravies, as described herein, are broadly defined. Gravies may be any gravy, topping, sauce, or other liquid mixture. Gravies may have a viscosity which is greater than distilled water at ambient temperature. Gravies may be orally administered directly to the companion animal, but are advantageously contacted or admixed with food prior to oral administration.
  • The compositions may optionally comprise at least about 50% water, by weight of the composition. In alternative embodiments, the compositions comprise at least about 60% water, at least about 70% water, at least about 80% water, from about 50% to about 99% water, from about 60% to about 97% water, from about 70% to about 95% water, or from about 75% to about 90% water, all by weight of the composition. The water included at these levels includes all added water and any water present in combination components, for example, broths.
  • Optional Components of the Present Compositions
  • The compositions herein may comprise additional optional components to enhance, for example, their performance in providing gastrointestinal health, other health benefits, a desirable nutritional profile, and/or organoleptic properties. Such optional components may be dispersed, solubilized, or otherwise mixed into the present compositions. Non-limiting examples of optional components suitable for use herein are given below.
  • Meats, Broths, and Fats
  • Any of a variety of animal meats, broths, or fats may be utilized as components of the present compositions. For example, animal meats such as chicken, pork, beef, veal, fish, and the like may be utilized. Advantageously, such meats are in particle or chunk form, such that the composition maintains an overall liquid form, such as spray-dried animal meats. Broths and fats of any animal meats may be used.
  • Flavors
  • The meats, broths, or fats mentioned herein may also be utilized as a flavor to enhance palatability of the composition. Optionally, one or more other flavors may additionally or alternatively be utilized. Any natural or synthetic flavor can be used in the present invention.
  • Flavors may be those which are meat flavors, for example, by utilizing a meat source or a flavor which simulates a meat flavor. For example, yeast may be utilized to simulate chicken flavor as desired. Other natural or synthetic meat extracts may be used. Moreover, as another example, vegetable flavors or flavors which simulate the properties of vegetable flavors may be utilized.
  • The flavor agent can also comprise a blend of various flavors. If desired, the flavor in the flavoring agent may be formed into emulsion droplets which are then dispersed in the composition. Typically the flavoring agents are conventionally available as concentrates or extracts or in the form of synthetically produced flavoring esters, alcohols, aldehydes, terpenes, sesquiterpenes, and the like.
  • pH
  • The present compositions may have any pH, provided that the composition is adapted for use, particularly ingestion, by a companion animal. In optional embodiments of the present invention, the present compositions have a pH of less than about 7, less than about 6, less than about 5, less than about 4, less than about 3.5, from about 2 to about 7, from about 2.5 to about 5, from about 2.5 to about 4, or from about 2.5 to about 3.5. Those compositions having a pH of less than about 3.5 are particularly preferred, as these compositions may not require refrigeration upon exposure to air such to provide shelf-stability over time and may not require aseptic packaging processes.
  • If necessary, the present compositions may comprise one or more acidulants in order to reach, and maintain, the desired pH. Acidity can be adjusted to and maintained within the requisite range by known and conventional methods, e.g., the use of one or more acidulants.
  • Organic as well as inorganic edible acids may be used to adjust the pH of the compositions. The acids can be present in their undissociated form or, alternatively, as their respective salts, for example, potassium or sodium hydrogen phosphate, potassium or sodium dihydrogen phosphate salts. Illustrative acids are edible organic acids which include citric acid, malic acid, fumaric acid, adipic acid, phosphoric acid, gluconic acid, tartaric acid, ascorbic acid, acetic acid, phosphoric acid or mixtures thereof.
  • The amount of edible acid utilized will, of course, be dependent at least in part upon desired acidity. As an example, the compositions may comprise from about 0.01% to about 5% edible acid, from about 0.1% to about 4% edible acid, from about 0.5% to about 3% edible acid, or from about 0.7% to about 2% edible acid, all by weight of the composition.
  • Omega-3-Fatty Acids
  • One or more omega-3-fatty acids may be added to the present compositions. The omega-3-fatty acid optionally utilized herein may be any omega-3-fatty acid or combination of omega-3-fatty acids. Non-limiting examples of omega-3-fatty acids which are suitable for use herein include eicosapentaenoic acid (also known as EPA), docosahexaenoic acid (also known as DHA), and mixtures thereof. Omega-3-fatty acids are often sourced from marine (fish) sources, including menhaden (a herring-like fish), or other sources such as flax.
  • Nutrients
  • The compositions herein may optionally, but preferably, be fortified further with one or more nutrients, especially one or more vitamins and/or minerals. Non-limiting examples of such vitamins and minerals, include niacin, thiamin, folic acid, pantothenic acid, biotin, vitamin A (including vitamin A (retinol), β-carotene, retinol palmitate, or retinol acetate), vitamin C, vitamin B2, vitamin B3, vitamin B6, vitamin B12, vitamin D, vitamin E, vitamin K, iron, zinc, copper, phosphorous, iodine, chromium, molybdenum, fluoride, calcium, manganese, magnesium, or boron.
  • Preservatives
  • One or more preservatives may additionally be utilized herein. Preferred preservatives include, for example, sorbate, benzoate, and polyphosphate preservatives. Preservatives may be avoided wherein the pH is manipulated to levels which are less than about 3.5.
  • Thickeners and Bulking Agents
  • The compositions according to the present invention may optionally further comprise one or more thickeners, including xanthan gum, carboxymethylcellulose, carboxyethylcellulose, hydroxypropylcellulose, methylcellulose, microcrystalline cellulose, starches, dextrins, fermented whey, tofu, maltodextrins, propylene glycol alginate, gellan gum, guar gum, pectin, tragacanth gum, gum acacia, locust bean gum, gum arabic, gelatin, as well as mixtures of these thickeners. Some of these thickeners may also be utilized as a fermentable fiber source.
  • Emulsifiers and Oils
  • One or more emulsifiers and/or oils may also be included in the present compositions for texture and opacity purposes. Typical emulsifiers and oils useful herein include, for example, mono-di glycerides, lecithin, pulp, cottonseed oil, and vegetable oil.
  • Vegetables
  • Optionally one or more vegetables may be included in the present compositions. Examples of such vegetables include celery, potato, tomato, pea, carrot, and the like. Vegetables may be dehydrated vegetables which are minced, diced, or otherwise prepared such that the particle size is controlled as desired.
  • Kits of the Present Invention
  • The present invention further relates to kits comprising the foregoing compositions and information, such that the consumer (including companion animal guardian, breeder, veterinarian, or the like) will readily comprehend benefits of the present compositions. In particular, the kits comprise:
      • (a) a composition described herein; and
      • (b) information selected from the group consisting of:
        • (i) that the composition is adapted for use by a companion animal;
        • (ii) that the composition is useful for enhancing gastrointestinal health;
        • (iii) that the composition is useful for improving the fecal odor of the feces of a companion animal; and
        • (iv) combinations thereof.
  • The kits of the present invention may comprise one or more compositions together with information which informs a user of the kit, by words, pictures, and/or the like, that use of the kit is useful for enhancement of gastrointestinal health of the companion animal, or that the composition is adapted for use by a companion animal. Such information need not utilize the actual terms used herein, for example, “gastrointestinal”, “companion”, or “adapted for use”, but rather use of words or terms, pictures, symbols, and the like conveying the same or similar meaning are contemplated within the scope of this invention.
  • In a particularly preferred embodiment, the information is printed on a container holding the composition, e.g., a bottle. These preferred kits may be in the form of one bottle containing the composition, or may be obtained as a plurality of bottles each containing the composition. For example, the kits may be obtained as one bottle, or cases of four, six, seven or eight bottles co-packaged together. Each container may hold a variety of quantities of composition; for example, the container may contain a single dose or multiple doses of the composition.
  • Methods of the Present Invention
  • The methods of the present invention comprise orally administering (i.e., through ingestion) a composition of the present invention to a companion animal to provide improvement in gastrointestinal health and/or improvement in the fecal odor of the feces of the companion animal, as applicable. In one embodiment herein, the enhancement of gastrointestinal health may include any one or more of the following benefits: therapeutically relieving the symptoms of, or prevention of, gastrointestinal inflammatory disorders, inflammatory bowel disease, diarrhea or loose stools; otherwise improving fecal quality; weight loss associated with diarrhea or loose stools; treatment of small intestine bacterial overgrowth; or manipulation of levels of bacteria including improving levels of beneficial bacteria relative to harmful bacteria and/or decreasing pathogenic bacteria. Moreover, ancillary benefits to improvement in the fecal odor of the feces of the companion animal include removal of putrefactive substances which are known to promote, either directly or indirectly, carcinogenic effects in the mammalian system. Therefore, reducing pro-carcinogenic substances or effects, specifically reducing risk of cancer, is a useful benefit herein. Various methods of analysis directed to these benefits are described herein below.
  • The compositions of the present invention are most preferably ingested by companion animals. The compositions may be ingested as a supplement to normal dietetic requirements.
  • As used herein, the term “orally administering” with respect to the companion animal means that the animal ingests or a human is directed to feed, or does feed, the animal one or more compositions herein. Wherein the human is directed to feed the composition, such direction may be that which instructs and/or informs the human that use of the composition may and/or will provide the referenced benefit, for example, an enhanced gastrointestinal health benefit. For example, such direction may be oral direction (e.g., through oral instruction from, for example, a veterinarian or other health professional), radio or television media (i.e., advertisement), or written direction (e.g., through written direction from, for example, a veterinarian or other health professional (e.g., scripts), sales professional or organization (e.g., through, for example, marketing brochures, pamphlets, or other instructive paraphernalia), written media (e.g., internet, electronic mail, or other computer-related media)), and/or packaging associated with the composition (e.g., a label present on a container holding the composition). As used herein, “written” means through words, pictures, symbols, and/or other visible descriptors. Such information need not utilize the actual words used herein, for example, “gastrointestinal”, “companion”, or “adapted for use”, but rather use of words, pictures, symbols, and the like conveying the same or similar meaning are contemplated within the scope of this invention.
  • The compositions described herein may be used as a supplement to ordinary dietetic requirements, or may be nutritionally balanced for those companion animals which have difficulty ingesting solid foods. Administration may be on an as-needed or as-desired basis, for example, once-monthly, once-weekly, or daily (including multiple times daily, or with each feeding). When utilized as a supplement to ordinary dietetic requirements, the composition may be administered directly to the companion animal or otherwise contacted with or admixed with companion animal food. The amount of composition utilized may be dependent on a variety of factors, including the quality of gastrointestinal health of the animal, preference of the animal as determined by the guardian of the animal or other person administering the composition, the quality of the companion animal food, and size or breed or the companion animal.
  • Methods of Analysis
  • The present compositions may be utilized to enhance the gastrointestinal health of the companion animal or improve fecal odor of the feces of the companion animal. Various methods of demonstrating such enhancements or improvements are well-known to those of ordinary skill in the art. As examples, the following provides illustrations of certain methods which may be used. These methods are not intended to limit the scope of the invention.
  • Methods of Enhancing Gastrointestinal Health: Methods of measuring enhancements in gastrointestinal health of a companion animal will be well-known to those having ordinary skill in the art. An illustrative example of making such measurements is set forth in U.S. Pat. No. 5,952,033, which follows the general method described above with respect to measurement of fecal odor, with the following modifications: The levels of short chain fatty acids in the fecal matter are determined by gas chromatograph. The results indicate that administration of the test food results in increased short chain fatty acid concentrations relative to administration of the control food, which is believed to contribute to improved gastrointestinal health.
  • Additionally or alternatively, the compositions herein may be measured by their ability to reduce the amount of harmful bacteria in the small intestine (also referenced as treating small intestinal bacterial overgrowth, or IBO). Such methods are described in Reinhart, U.S. Pat. No. 5,776,524 (1998).
  • Additionally or alternatively, as one of ordinary skill in the art will recognize, fecal matter quality may also be indicative of gastrointestinal health. The treatment or prevention of gastrointestinal infection, including diarrhoea, in companion animals may be measured using stool scores. Stools scores may be recorded daily according to the following guidelines and control and test groups compared before and after administering the compositions according to the present invention.
  • Score: 5 Extremely Dry
  • This stool is hard and does not stick to surfaces. Stool will roll when pushed. No indentations are made when stool is picked up. Stool is often defecated in groups of individual stools instead of one complete unit. The stool maintains original shape after collection.
  • Score: 4 Firm (Ideal Stool)
  • This stool is firm, well shaped, and cylindrical. This stool does not break apart easily when picked up. This stool may leave residue on surfaces and gloves. This stool is often defecated as one unit. The stool maintains original shape after collection.
  • Score: 3 Soft, with Shape
  • This stool is soft, however there are definite shapes. This stool will break apart easily and will definitely leave residue on surfaces and gloves. The stool often loses original shape after collection. This stool is often present with another score but can comprise whole stool sample.
  • Score: 2 Soft, without Shape
  • This stool is soft and will have no cylindrical shape. The shape often associated with a “2” is a “cow patty” shape. This stool will lose the original shape when collected and will definitely leave residue on surfaces and gloves. This stool score is often present with another score but can comprise the whole stool sample. This stool sample may spread over an area of several inches.
  • Score: 1 Liquid
  • This stool score will always resemble liquid and there may or may not be particulate matter present. This stool will often be defecated in groups of piles instead of one complete unit. Mucous is often present with this stool sample. This stool sample is very difficult to collect and residue is always left on surfaces and gloves. This stool sample may spread over an area of several inches.
  • In addition, other observations are also recorded, including: blood in stool; foreign object in stool; or mucous in stool.
  • Furthermore, the enhancement of gastrointestinal health in companion animals may comprise improving microbial ecology of companion animals. Improving the microbial ecology of companion animals preferably comprises reducing the levels of pathogenic bacteria in the feces of companion animals. The levels of pathogenic bacteria present in the feces of companion animals may be enumerated using the standard plate count method known to those skilled in the art. More preferably, the pathogenic bacteria are selected from the group consisting of Clostridia, Escherichia, Salmonella, Bacteriodes and mixtures thereof. Non-limiting examples of suitable strains of pathogenic bacteria include B. fragilis, C. perfringens, C. difficile, Eschericia coli, Salmonella typhimurium and mixtures thereof.
  • Improvement of Fecal Odor of the Feces of a Companion Animal: Methods of measuring improvement of fecal odor of the feces of a companion animal will be well-known to those having ordinary skill in the art. An illustrative example of making such measurements is set forth in U.S. Pat. No. 5,952,033, which generally instructs as follows: A trial is conduct using a defined number of dogs. The control food is provided, wherein the control food is a commercially available dry dog food (which is nutritionally balanced) which is devoid of short chain oligofructose. A test food is provided which corresponds to the control food except that it includes from about 0.01% to about 0.2% of short chain oligofructose, by weight of the food, as described herein. Half of the dogs are fed the control food and the remaining half are fed the test food. Fecal samples are collected from each dog, heated for 2 hours at 30° C., and the compounds released are trapped on a Tenax tube, or equivalent. The trapped compounds are desorbed on a gas chromatograph. The levels of dimethylsulfide, dimethldisulfide, and dimethyltrisulfide are determined for each of the control and test foods. The results indicate that administration of the test food results in improved fecal odor relative to administration of the control food, as measured by decreases in the levels of dimethylsulfide, dimethldisulfide, and dimethyltrisulfide, which are believed to cause unpleasant odor.
  • Methods of Making
  • The presently described compositions are made according to methods which will be well known by the ordinarily skilled artisan. To illustrate, the compositions of the present invention may be prepared by dissolving, dispersing, or otherwise mixing all components singularly or in suitable combinations together, and in water where appropriate, agitating with a mechanical stirrer until all of the ingredients have been solubilized or adequately dispersed.
  • An example of a process which may be utilized to manufacture the present compositions may be adapted in accordance with the following general disclosure (all non-requisite components are set forth to demonstrate illustrative components):
      • 1. Add water to tank.
      • 2. Add any antioxidant to animal fat and mix well.
      • 3. Under constant agitation, add liquid fructooligosaccharide and animal fat to the water. Mix thoroughly.
      • 4. Pre-mix any animal solids, broth powder, xanthan gum, vitamin and mineral pre-mixes, and yeast to form a “meat pre-mix”.
      • 5. Under constant agitation, slowly add meat pre-mix and mix well to ensure powder is well dispersed. (Alternatively, the xantham gum could be added using well-known high shear techniques to ensure adequate dispersion of the gum. Other solids can also be added individually with constant mixing.)
      • 6. Pass product batch through a disintegrator or other high shear dispersing equipment to ensure all powders (particularly the gum) is well dispersed and no large clumps of powder remain.
      • 7. Pre-mix vegetables ingredients into a “vegetable pre-mix”, including beet pulp, flax and vegetables.
      • 8. Slowly add vegetable pre-mix to batch under constant agitation. Mix well.
      • 9. Heat batch to 195° F. and hold for 5 minutes.
      • 10. Cool batch to at least 130° F.
      • 11. Add ½ of predicted level of phosphoric acid and mix well.
      • 12. Add potassium sorbate, mix well.
      • 13. Add flavors and mix.
      • 14. Add additional phosphoric acid to achieve the target pH. Mix well.
    EXAMPLES
  • The following are non-limiting examples of the present compositions which are prepared utilizing conventional methods. The following examples are provided to illustrate the invention and are not intended to limit the scope thereof in any manner.
  • Example 1
  • A beef-flavor gravy composition is prepared by combining the following components in a conventional manner:
    Component Wt %
    Fructooligosaccharide 5.3
    Chicken Fat 3.0
    Spray-Dried Beef Particles and Broth 3.0
    Xanthan Gum 0.5
    Flax Seed 0.2
    Vegetables 0.2
    Vitamins 0.06
    Minerals 0.04
    Phosphoric Acid 0.95
    Beef Flavor 0.1
    Water Remainder
  • One fluid ounce of the gravy composition is admixed with one-half cup of standard dog kibble diet daily prior to feeding to a dog. Amounts of the gravy composition are determined as desired by the guardian of the dog.
  • Example 2
  • A chicken-flavor gravy composition is prepared by combining the following components in a conventional manner:
    Component Wt %
    Short Chain Oligofructose (NUTRAFLORA, 5.3
    commercially available from GTC Nutrition,
    Golden, CO., U.S.A.)
    Chicken Fat 3.0
    Spray-Dried Chicken Particles and Broth 3.0
    Beet Pulp 0.4
    Xanthan Gum 0.5
    Flax Seed 0.15
    Vegetables 0.2
    Vitamins 0.06
    Minerals 0.04
    Phosphoric Acid 0.95
    Chicken Flavor 0.53
    Water Remainder
  • Two fluid ounces of the gravy composition is admixed with one-half cup of standard dog kibble diet daily prior to feeding to a dog.
  • Example 3
  • The following illustrates how to use the present compositions. Twenty-four dogs having intestinal bacterial overgrowth are used to determine the effects of the composition according to Example 1 on the dog gastrointestinal system. The dogs are of age ranging from 12 months to 24 months old. The dogs are fed an initial diet (Diet A) for two months. Diet A contains no fermentable fiber, but each feeding contains 10 ounces of kibble containing chicken by-product meal, corn, chicken fat, rice, Brewers yeast, egg, nutrients, and corn starch, which is admixed with 2 ounces of a gravy in accordance with Example 1 except that water substitutes for the fructooligosaccharide and beet pulp. Intestinal juice and mucosal tissue from the dogs is sampled and cultured at conclusion of feeding Diet A. Twenty-eight days afterwards, the dogs are fed Diet B, which is same kibble utilized in Diet A but mixed with the composition according to Example 1. Intestinal juice, mucosal tissue, and fresh fecal samples are re-sampled 6 weeks after starting Diet B. The intestinal juice and mucosal tissue are sampled for aerobic and anaerobic bacteria. The dogs ingesting Diet B show significantly fewer aerobic and anaerobic bacteria in the intestinal juice and mucosa, and beneficical (Bifidobacteria, Lactobacilli, Eubacteria) and pathogenic (B. fragilis, C. perfringens, C. difficile, Eschericia coli) in the intestinal juice, mucosa, and fecal samples relative to sampling occurring upon ingestion of Diet A.
  • All documents cited in the Detailed Description of the Invention are, in relevant part, incorporated herein by reference; the citation of any document is not to be construed as an admission that it is prior art with respect to the present invention.
  • While particular embodiments of the present invention have been illustrated and described, it would be obvious to those skilled in the art that various other changes and modifications can be made without departing from the spirit and scope of the invention. It is therefore intended to cover in the appended claims all such changes and modifications that are within the scope of this invention.

Claims (52)

1. A composition comprising at least about 0.25% of total fermentable fiber, by weight of the composition, wherein the composition is a liquid which is adapted for use by a companion animal.
2. The composition according to claim 1 comprising at least about 0.5% of total fermentable fiber, by weight of the composition.
3. The composition according to claim 2 which is a drinking water.
4. The composition according to claim 3 wherein the total fermentable fiber comprises a fiber selected from the group consisting of beet pulp, gum arabic, gum talha, psyllium, rice bran, carob bean gum, citrus pulp, pectin, fructooligosaccharide, mannanoligofructose, soy fiber, arabinogalactan, galactooligosaccharide, arabinoxylan, and mixtures thereof.
5. The composition according to claim 4 wherein the total fermentable fiber comprises a fiber selected from the group consisting of beet pulp, fructooligosaccharide, and mixtures thereof.
6. The composition according to claim 1 which is a gravy.
7. The composition according to claim 6 wherein the total fermentable fiber comprises a fiber selected from the group consisting of beet pulp, gum arabic, gum talha, psyllium, rice bran, carob bean gum, citrus pulp, pectin, fructooligosaccharide, mannanoligofructose, soy fiber, arabinogalactan, galactooligosaccharide, arabinoxylan, and mixtures thereof.
8. The composition according to claim 7 comprising at least about 0.5% of total fermentable fiber, by weight of the composition.
9. The composition according to claim 8 further comprising one or more nutrients.
10. The composition according to claim 9 further comprising meat protein.
11. The composition according to claim 10 comprising at least about 0.5% protein and at least about 1% fat, by weight of the composition.
12. The composition according to claim 11 wherein the total fermentable fiber comprises a fiber selected from the group consisting of beet pulp, fructooligosaccharide, and mixtures thereof.
13. The composition according to claim 12 wherein the total fermentable fiber comprises beet pulp and fructooligosaccharide.
14. A composition comprising a fermentable fiber selected from the group consisting of beet pulp, short chain oligofructose comprising 1-kestose, nystose, and 1F-beta-fructofuranosylnystose, and mixtures thereof, wherein the composition is a liquid which is adapted for use by a companion animal.
15. The composition according to claim 14 comprising at least about 0.05% of total fermentable fiber, by weight of the composition.
16. The composition according to claim 15 which is a drinking water.
17. The composition according to claim 16 comprising from about 0.1% to about 20% of total fermentable fiber, by weight of the composition.
18. The composition according to claim 15 which is a gravy.
19. The composition according to claim 18 comprising from about 0.1% to about 20% of total fermentable fiber, by weight of the composition.
20. The composition according to claim 19 further comprising a further fermentable fiber selected from the group consisting of beet pulp, gum arabic, gum talha, psyllium, rice bran, carob bean gum, citrus pulp, pectin, fructooligosaccharide additional to the short chain oligofructose, mannanoligofructose, soy fiber, arabinogalactan, galactooligosaccharide, arabinoxylan, and mixtures thereof.
21. The composition according to claim 19 further comprising one or more nutrients.
22. The composition according to claim 21 further comprising meat protein.
23. The composition according to claim 22 comprising at least about 0.5% protein and at least about 1% fat, by weight of the composition.
24. A kit comprising:
(a) the composition according to claim 1; and
(b) information selected from the group consisting of:
(i) that the composition is adapted for use by a companion animal;
(ii) that the composition is useful for enhancing gastrointestinal health;
(iii) that the composition is useful for improving the fecal odor of the feces of a companion animal; and
(iv) combinations thereof.
25. The kit according to claim 24 wherein the composition comprises at least about 0.5% of total fermentable fiber, by weight of the composition.
26. The kit according to claim 25 wherein the total fermentable fiber comprises a fiber selected from the group consisting of beet pulp, gum arabic, gum talha, psyllium, rice bran, carob bean gum, citrus pulp, pectin, fructooligosaccharide, mannanoligofructose, soy fiber, arabinogalactan, galactooligosaccharide, arabinoxylan, and mixtures thereof.
27. The kit according to claim 26 wherein the composition comprises from about 1% to about 20% of total fermentable fiber, by weight of the composition.
28. The kit according to claim 27 wherein the composition is a drinking water.
29. The kit according to claim 27 wherein the composition is a gravy.
30. The kit according to claim 29 wherein the composition comprises from about 2% to about 10% of total fermentable fiber, by weight of the composition.
31. A kit comprising:
(a) the composition according to claim 14; and
(b) information selected from the group consisting of:
(i) that the composition is adapted for use by a companion animal;
(ii) that the composition is useful for enhancing gastrointestinal health;
(iii) that the composition is useful for improving the fecal odor of the feces of a companion animal; and
(iv) combinations thereof.
32. The kit according to claim 31 wherein the composition comprises at least about 0.05% of total fermentable fiber, by weight of the composition.
33. The kit according to claim 32 wherein the composition further comprises a further fermentable fiber selected from the group consisting of beet pulp, gum arabic, gum talha, psyllium, rice bran, carob bean gum, citrus pulp, pectin, fructooligosaccharide additional to the short chain oligofructose, mannanoligofructose, soy fiber, arabinogalactan, galactooligosaccharide, arabinoxylan, and mixtures thereof.
34. The kit according to claim 32 wherein the composition comprises from about 0.1% to about 20% of total fermentable fiber, by weight of the composition.
35. The kit according to claim 34 wherein the composition is a drinking water.
36. The kit according to claim 34 wherein the composition is a gravy.
37. A method selected from the group consisting of enhancing gastrointestinal health of a companion animal, improving the fecal odor of the feces of a companion animal, reducing risk of cancer in a companion animal, and combinations thereof, comprising orally administering to the companion animal the composition according to claim 1.
38. The method according to claim 37 wherein the method comprises at least about 0.5% of total fermentable fiber, by weight of the composition.
40. The method according to claim 38 wherein the total fermentable fiber comprises a fiber selected from the group consisting of beet pulp, gum arabic, gum talha, psyllium, rice bran, carob bean gum, citrus pulp, pectin, fructooligosaccharide, mannanoligofructose, soy fiber, arabinogalactan, galactooligosaccharide, arabinoxylan, and mixtures thereof.
41. The method according to claim 40 wherein the composition is a drinking water.
42. The method according to claim 40 wherein the composition is a gravy.
43. The method according to claim 42 wherein the oral administration is at least once daily.
44. The method according to claim 42 wherein the composition is contacted with companion animal food prior to oral administration.
45. The method according to claim 42 wherein the composition is admixed with companion animal food prior to oral administration.
46. A method selected from the group consisting of enhancing gastrointestinal health of a companion animal, improving the fecal odor of the feces of a companion animal, reducing risk of cancer in a companion animal, and combinations thereof, comprising orally administering to the companion animal the composition according to claim 14.
47. The method according to claim 46 wherein the composition comprises at least about 0.05% of total fermentable fiber, by weight of the composition.
48. The method according to claim 47 wherein the composition is a drinking water.
49. The method according to claim 47 wherein the composition is a gravy.
50. The method according to claim 49 wherein the oral administration is at least once daily.
51. The method according to claim 50 wherein the oral administration is concurrent with feeding the companion animal.
52. The method according to claim 49 wherein the composition is contacted with companion animal food prior to oral administration.
53. The method according to claim 49 wherein the composition is admixed with companion animal food prior to oral administration.
US10/725,248 2003-12-01 2003-12-01 Compositions comprising fermentable fiber which are adapted for use by a companion animal and kits and methods of their use Abandoned US20050119222A1 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
US10/725,248 US20050119222A1 (en) 2003-12-01 2003-12-01 Compositions comprising fermentable fiber which are adapted for use by a companion animal and kits and methods of their use
BRPI0417166-7A BRPI0417166A (en) 2003-12-01 2004-12-01 compositions comprising fermentable fiber adapted for use by a pet and kits and methods for using them
JP2006541496A JP2007512024A (en) 2003-12-01 2004-12-01 Compositions and kits containing fermentable fibers adapted for use by companion animals and methods for their use
AU2004295003A AU2004295003B2 (en) 2003-12-01 2004-12-01 Compositions comprising fermentable fiber which are adapted for use by a companion animal and kits and methods of their use
CA2547330A CA2547330C (en) 2003-12-01 2004-12-01 Compositions comprising fermentable fiber which are adapted for use by a companion animal and kits and methods of their use
PCT/US2004/040084 WO2005053425A1 (en) 2003-12-01 2004-12-01 Compositions comprising fermentable fiber which are adapted for use by a companion animal and kits and methods of their use
EP04812571.0A EP1689247B1 (en) 2003-12-01 2004-12-01 Compositions comprising fermentable fiber which are adapted for use by a companion animal and kits and methods of their use
ARP040104488A AR046743A1 (en) 2003-12-01 2004-12-02 COMPOSITIONS THAT INCLUDE FERMENTABLE FIBER WHICH ARE ADAPTED TO BE USED BY A COMPANY ANIMAL AND CASES AND METHODS FOR USE
US15/294,503 US10681922B2 (en) 2003-12-01 2016-10-14 Methods of enhancing the gastrointestinal health of a companion animal

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/725,248 US20050119222A1 (en) 2003-12-01 2003-12-01 Compositions comprising fermentable fiber which are adapted for use by a companion animal and kits and methods of their use

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US15/294,503 Division US10681922B2 (en) 2003-12-01 2016-10-14 Methods of enhancing the gastrointestinal health of a companion animal

Publications (1)

Publication Number Publication Date
US20050119222A1 true US20050119222A1 (en) 2005-06-02

Family

ID=34620268

Family Applications (2)

Application Number Title Priority Date Filing Date
US10/725,248 Abandoned US20050119222A1 (en) 2003-12-01 2003-12-01 Compositions comprising fermentable fiber which are adapted for use by a companion animal and kits and methods of their use
US15/294,503 Active 2025-02-20 US10681922B2 (en) 2003-12-01 2016-10-14 Methods of enhancing the gastrointestinal health of a companion animal

Family Applications After (1)

Application Number Title Priority Date Filing Date
US15/294,503 Active 2025-02-20 US10681922B2 (en) 2003-12-01 2016-10-14 Methods of enhancing the gastrointestinal health of a companion animal

Country Status (8)

Country Link
US (2) US20050119222A1 (en)
EP (1) EP1689247B1 (en)
JP (1) JP2007512024A (en)
AR (1) AR046743A1 (en)
AU (1) AU2004295003B2 (en)
BR (1) BRPI0417166A (en)
CA (1) CA2547330C (en)
WO (1) WO2005053425A1 (en)

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030195166A1 (en) * 2000-03-10 2003-10-16 Marie-Louise Baillon Treatment of infection in animals
US20060148378A1 (en) * 2004-12-30 2006-07-06 The United States Of America, As Represented By The Secretary Of Agriculture Artificial diets for honey bees
US20080038385A1 (en) * 2006-03-13 2008-02-14 Nutracea Therapeutic uses of an anti-cancer composition derived from rice bran
US20100215738A1 (en) * 2009-02-24 2010-08-26 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
US20100316732A1 (en) * 2008-02-12 2010-12-16 Todd James Smith Beverage compositions for the promotion of joint health in companion animals
US20110223248A1 (en) * 2007-12-12 2011-09-15 Ritter Pharmaceuticals, Inc. Methods and compositions for treating lactose intolerance
US20110236480A1 (en) * 2009-02-24 2011-09-29 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
US8409585B2 (en) 2007-10-15 2013-04-02 Jbs United, Inc. Method for increasing performance of offspring
US9149056B2 (en) 2011-01-14 2015-10-06 The Iams Company Compositions and methods relating to carotenoids
US9226933B2 (en) 2004-07-22 2016-01-05 Ritter Pharmaceuticals, Inc. Methods and compositions for treating lactose intolerance
CN106470555A (en) * 2014-06-18 2017-03-01 尤妮佳股份有限公司 Pet food plastochondria and pet food
US10681922B2 (en) 2003-12-01 2020-06-16 Mars, Incorporated Methods of enhancing the gastrointestinal health of a companion animal

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8685943B2 (en) * 2003-03-12 2014-04-01 Hill's Pet Nutrition, Inc. Methods for reducing diarrhea in a companion animal
WO2009008882A1 (en) * 2007-07-09 2009-01-15 Hill's Pet Nurtition, Inc. Compositions and methods for altering stool quality in an animal
US8529965B2 (en) 2007-07-09 2013-09-10 Hill's Pet Nutrition, Inc. Compositions and methods for altering stool quality in an animal
EP2222310B1 (en) * 2007-10-11 2016-08-03 Promovita ingredients limited Preparation for treating intestinal infection comprising oligosaccharides and insoluble cellular material
US20170056462A1 (en) * 2014-04-25 2017-03-02 Nexira International Use of a composition comprising arabic gum (ag) for improving gut impermeability
JP6301024B2 (en) * 2016-03-14 2018-03-28 物産フードサイエンス株式会社 Felicaribacterium spp.

Citations (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3119691A (en) * 1962-04-23 1964-01-28 Gen Foods Corp Novel farinaceous animal food
US4241093A (en) * 1978-05-11 1980-12-23 U and I, Incorporated Food supplement from vegetable pulp and method of preparing same
US4551351A (en) * 1984-02-09 1985-11-05 Fuji Oil Company, Limited Process for producing meat block-like protein material
US4927811A (en) * 1988-11-15 1990-05-22 Coors Biotech, Inc. Method and composition for improved animal husbandry
US5116629A (en) * 1990-10-24 1992-05-26 General Mills, Inc. Processed meat products containing fish oils stabilized with fructose
US5221552A (en) * 1990-08-27 1993-06-22 Nihon Tensaiseito Kabushiki Kaisha Porridgelike dietary fiber, foods containing the same, and method for producing porridgelike dietary fiber
US5294458A (en) * 1992-04-03 1994-03-15 Maruha Corporation Pet food
US5616569A (en) * 1994-03-28 1997-04-01 The Iams Company Pet food product containing fermentable fibers and process for treating gastrointestinal disorders
RU2142720C1 (en) * 1999-03-02 1999-12-20 Северо-Кавказский научно-исследовательский институт сахарной свеклы и сахара Method for producing alimentary fiber from beet pulp
US6248390B1 (en) * 2000-02-22 2001-06-19 Suzanne Jaffe Stillman Fiber-water—water containing soluble fiber
US6383534B1 (en) * 2000-01-18 2002-05-07 Lorin Dyrr Mineral water composition
US20020054923A1 (en) * 2000-09-05 2002-05-09 Kao Corporation Agent for preventing, improving or treating hypertension
WO2002096211A1 (en) * 2001-05-30 2002-12-05 Sadia S/A. An alimentary composition comprising dietary fibres, as well as the use thereof in the preparation of alimentary products
US20030099759A1 (en) * 2001-09-25 2003-05-29 Hill's Pet Nutrition, Inc. New pet food composition and method
US6596332B1 (en) * 1996-12-24 2003-07-22 Nestec S.A. Gelatinized cereal product containing oligosaccharide
US20030190309A1 (en) * 2000-05-25 2003-10-09 Ralf Zink Novel probiotics for pet food applications
US20030194423A1 (en) * 2002-04-15 2003-10-16 Mars, Inc. Composition for enhancing nutritional content of food

Family Cites Families (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1549196A (en) * 1975-06-17 1979-08-01 Mars Ltd Food product and process
GB915039A (en) * 1961-05-01 1963-01-09 Gen Foods Corp A readily hydratable animal food and method for the preparation thereof
US4134901A (en) * 1968-07-01 1979-01-16 Lever Brothers Company Flavoring substances
US3908025A (en) 1972-09-21 1975-09-23 Ralston Purina Co Pet food product and method for forming same
US3876794A (en) * 1972-12-20 1975-04-08 Pfizer Dietetic foods
DE2403203B2 (en) 1974-01-23 1975-11-13 Franz 2845 Damme Leiber Process for processing brewer's grains
US4020187A (en) 1974-12-09 1977-04-26 Theracon, Inc. Method of producing dry pet food
CH570117A5 (en) 1974-12-12 1975-12-15 Eichholzer Ag Feed additive for agricultural animals - prepd. by air-drying extn. residues of coffee beans in coffee mfr.
SE442023B (en) 1981-02-11 1985-11-25 Svensk Exergiteknik Ab PROCEDURE FOR PREPARING BETMAS FROM SUGAR BEETER AND DEVICE FOR IMPLEMENTATION OF THE PROCEDURE
US4343823A (en) * 1981-04-03 1982-08-10 Kalsec, Inc. Liquid seasoning compositions IV
JPS6034134A (en) 1983-08-05 1985-02-21 Meiji Seika Kaisha Ltd Feed containing fructoligosaccharide and feeding of domestic animals therewith
CA1246556A (en) 1984-07-24 1988-12-13 Hiroshi Yamazaki Production of fructose syrup
JPS61135551A (en) 1984-12-06 1986-06-23 Fumio Kono Pet food
GB8431699D0 (en) 1984-12-14 1985-01-30 Mars G B Ltd Gel system
US5422136A (en) 1987-04-20 1995-06-06 Fuisz Technologies Ltd. Starch-based food enhancing ingredient
EP0293935B1 (en) 1987-06-05 1992-09-16 MITSUI TOATSU CHEMICALS, Inc. Additive for stock feeds, stock feed containing additive, and process for preparation of additive
JPH01252257A (en) 1987-06-05 1989-10-06 Mitsui Toatsu Chem Inc Feed additive, feed and production thereof
JPS63309147A (en) 1987-06-09 1988-12-16 Nippon Beet Sugar Mfg Co Ltd Production of feed additive
US4987124A (en) 1987-10-13 1991-01-22 Coors Biotech, Inc. Method for inhibiting the growth of salmonella
JPH01310663A (en) 1988-06-09 1989-12-14 Sanwa Kagaku Kenkyusho Co Ltd Composition derived from rice bran, deodorant for animal containing said composition and production thereof
JPH0361452A (en) 1989-07-31 1991-03-18 Kazuo Uranaka Mixed feed for livestock
JPH0416163A (en) 1990-05-02 1992-01-21 Nippon Synthetic Chem Ind Co Ltd:The Intestine-controlling composition
ES2033193B1 (en) 1990-10-30 1994-01-16 Ganadera Union Ind Agro FAT MIXTURE FOR CHILD AND ADULT NUTRITION.
US5085883A (en) 1991-06-27 1992-02-04 Abbott Laboratories Blend of dietary fiber for nutritional products
JP3257690B2 (en) 1992-02-10 2002-02-18 協同飼料株式会社 Feed for livestock with dietary fiber
DE4304394A1 (en) 1993-02-13 1993-09-02 Fresenius Ag Prepn. for nourishment of oncological patients - comprises fats formulation contg. oleic acid, alpha-linolenic acid, etc., and opt. carbohydrate and proteins
EP0680782A1 (en) 1994-05-06 1995-11-08 Coöperatie Suiker Unie U.A. Absorbent material comprising dried vegetable pulp and its use for treating organic waste
US5531989A (en) 1994-10-28 1996-07-02 Metagenics, Inc. Immunoglobulin and fiber-containing composition for human gastrointestinal health
EP0833570A1 (en) * 1995-06-06 1998-04-08 Campbell Soup Company Therapeutic system for dietary health management
US5776524A (en) 1996-10-30 1998-07-07 The Iams Company Process for treating small intestine bacterial overgrowth in animals
ES2164299T5 (en) 1997-01-09 2009-03-01 Societe Des Produits Nestle S.A. CEREAL PRODUCT CONTAINING PROBIOTICS.
US5965175A (en) 1997-03-27 1999-10-12 The Iams Company Composition and method for repartitioning nitrogen and increasing colonic blood flow in dogs to promote intestinal health
CN1203863C (en) 1997-04-07 2005-06-01 Iams公司 Process for improving glucose metabolism, satiety, and nutrient absorption in companion animals
US5958898A (en) 1997-04-07 1999-09-28 The Iams Company Process for altering the function and composition of gut associated lymphoid tissue in an animal
US5840361A (en) 1997-04-09 1998-11-24 Beech-Nut Nutrition Corporation Fructan-containing baby food compositions and methods therefor
EP0879600A1 (en) 1997-05-20 1998-11-25 Tiense Suikerraffinaderij N.V. (Raffinerie Tirlemontoise S.A.) Fructan containing composition for the prevention and treatment of colon cancer
US6039952A (en) 1997-10-22 2000-03-21 The Iams Company Composition and method for improving clinical signs in animals with renal disease
GB9723059D0 (en) * 1997-10-31 1998-01-07 Mars Uk Ltd Pet food
US6117477A (en) 1998-03-18 2000-09-12 Kal Kan Foods, Inc. Multicomponent food product and methods of making and using the same
US6117872A (en) 1998-06-23 2000-09-12 The Board Of Trustees Of The Leland Stanford Junior University Enhancement of exercise performance by augmenting endogenous nitric oxide production or activity
US6093418A (en) 1998-09-16 2000-07-25 The Iams Company Method for removing nitrogenous waste products from animals with hepatic disease
US6156355A (en) 1998-11-02 2000-12-05 Star-Kist Foods, Inc. Breed-specific canine food formulations
GB9905542D0 (en) 1999-03-10 1999-05-05 Mars Uk Ltd Pet food
US6468525B1 (en) 1999-08-10 2002-10-22 Renew Life, Inc. Probiotic formulation
EP1213970B1 (en) 1999-09-07 2008-06-11 Societe Des Produits Nestle S.A. Method for improving the skin and coat of pets
US7211280B1 (en) 1999-09-09 2007-05-01 Nestec S.A. Condition of elderly pets
BR0013879B1 (en) 1999-09-09 2013-07-23 non-therapeutic and nutraceutical method to improve health, increase longevity or increase the quality of life of an older pet, and pet food
AU777668B2 (en) 1999-09-22 2004-10-28 Societe Des Produits Nestle S.A. Method for increasing pet activity
US6669975B1 (en) 2000-02-03 2003-12-30 Mars Incorporated Customized dietary health maintenance system for pets
EP1125507A1 (en) 2000-02-15 2001-08-22 Tiense Suikerraffinaderij N.V. (Raffinerie Tirlemontoise S.A.) Inulin products with improved nutritional properties
WO2001064225A1 (en) 2000-03-01 2001-09-07 Societe Des Produits Nestle S.A. Carbohydrate formulation (prebiotic adjuvant) for enhancement of immune response
US7608291B2 (en) 2000-03-10 2009-10-27 Mars, Inc. Treatment of infection in animals
US20020132780A1 (en) 2001-01-12 2002-09-19 Heisey Matthew Thomas Low carbohydrate compositions, kits thereof, and methods of use
EP1243273A1 (en) 2001-03-22 2002-09-25 Societe Des Produits Nestle S.A. Composition comprising a prebiotic for decreasing infammatory process and abnormal activation of non-specific immune parameters
AT5522U1 (en) 2001-06-11 2002-08-26 Erber Ag FEED ADDITIVES FOR STABILIZING AND DIGESTIVE PROPERTY OF FARM ANIMALS
US20030138547A1 (en) 2002-01-22 2003-07-24 Mars, Incorporated Weight management system for animals
US20030194478A1 (en) 2002-04-12 2003-10-16 Davenport Gary Mitchell Dietary methods for canine performance enhancement
US20050119222A1 (en) 2003-12-01 2005-06-02 The Iams Company Compositions comprising fermentable fiber which are adapted for use by a companion animal and kits and methods of their use
US20050118299A1 (en) 2003-12-01 2005-06-02 The Iams Company Companion animal compositions comprising short chain oligofructose

Patent Citations (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3119691A (en) * 1962-04-23 1964-01-28 Gen Foods Corp Novel farinaceous animal food
US4241093A (en) * 1978-05-11 1980-12-23 U and I, Incorporated Food supplement from vegetable pulp and method of preparing same
US4551351A (en) * 1984-02-09 1985-11-05 Fuji Oil Company, Limited Process for producing meat block-like protein material
US4927811A (en) * 1988-11-15 1990-05-22 Coors Biotech, Inc. Method and composition for improved animal husbandry
US5221552A (en) * 1990-08-27 1993-06-22 Nihon Tensaiseito Kabushiki Kaisha Porridgelike dietary fiber, foods containing the same, and method for producing porridgelike dietary fiber
US5116629A (en) * 1990-10-24 1992-05-26 General Mills, Inc. Processed meat products containing fish oils stabilized with fructose
US5294458A (en) * 1992-04-03 1994-03-15 Maruha Corporation Pet food
US5616569A (en) * 1994-03-28 1997-04-01 The Iams Company Pet food product containing fermentable fibers and process for treating gastrointestinal disorders
US6596332B1 (en) * 1996-12-24 2003-07-22 Nestec S.A. Gelatinized cereal product containing oligosaccharide
RU2142720C1 (en) * 1999-03-02 1999-12-20 Северо-Кавказский научно-исследовательский институт сахарной свеклы и сахара Method for producing alimentary fiber from beet pulp
US6383534B1 (en) * 2000-01-18 2002-05-07 Lorin Dyrr Mineral water composition
US6248390B1 (en) * 2000-02-22 2001-06-19 Suzanne Jaffe Stillman Fiber-water—water containing soluble fiber
US20030190309A1 (en) * 2000-05-25 2003-10-09 Ralf Zink Novel probiotics for pet food applications
US20020054923A1 (en) * 2000-09-05 2002-05-09 Kao Corporation Agent for preventing, improving or treating hypertension
WO2002096211A1 (en) * 2001-05-30 2002-12-05 Sadia S/A. An alimentary composition comprising dietary fibres, as well as the use thereof in the preparation of alimentary products
US20030099759A1 (en) * 2001-09-25 2003-05-29 Hill's Pet Nutrition, Inc. New pet food composition and method
US20030194423A1 (en) * 2002-04-15 2003-10-16 Mars, Inc. Composition for enhancing nutritional content of food

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
(U1) Briggs, K. "Feeding Beet Pulp". American Association of Equine Practitioners. 2002-06-18 [Retrieved from the Internet on: 2012-12-09]. Retrieved from the Internet: . *
(V1) Hussein et al. J. Nutr. (December 1, 1998) vol. 128 no. 12, pp. 2803S-2805S. *
(W1) Grant et al. J. Dairy Sci. Volume 75, Issue 6, June 1992, Pages 1581-1587. *
(X1) "Mixture". Retrieved from the Internet on: 2015-02-18. Retrieved from: . *

Cited By (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7608291B2 (en) * 2000-03-10 2009-10-27 Mars, Inc. Treatment of infection in animals
US20030195166A1 (en) * 2000-03-10 2003-10-16 Marie-Louise Baillon Treatment of infection in animals
US10681922B2 (en) 2003-12-01 2020-06-16 Mars, Incorporated Methods of enhancing the gastrointestinal health of a companion animal
US9226933B2 (en) 2004-07-22 2016-01-05 Ritter Pharmaceuticals, Inc. Methods and compositions for treating lactose intolerance
WO2006073955A3 (en) * 2004-12-30 2006-11-23 Us Agriculture Artificial diets for honey bees
WO2006073955A2 (en) * 2004-12-30 2006-07-13 The United States Of America, As Represented By The Secretary Of Agriculture Artificial diets for honey bees
US8025552B2 (en) * 2004-12-30 2011-09-27 The United States Of America As Represented By The Secretary Of Agriculture Artificial diets for honey bees
US20060148378A1 (en) * 2004-12-30 2006-07-06 The United States Of America, As Represented By The Secretary Of Agriculture Artificial diets for honey bees
US20080038385A1 (en) * 2006-03-13 2008-02-14 Nutracea Therapeutic uses of an anti-cancer composition derived from rice bran
US10583159B2 (en) 2007-04-20 2020-03-10 United Animal Health, Inc. Method for increasing performance of offspring
US8409585B2 (en) 2007-10-15 2013-04-02 Jbs United, Inc. Method for increasing performance of offspring
US9675651B2 (en) 2007-10-15 2017-06-13 Jbs United, Inc. Method for increasing performance of offspring
US9272009B2 (en) 2007-10-15 2016-03-01 Jbs United, Inc. Method for increasing performance of offspring
US20110223248A1 (en) * 2007-12-12 2011-09-15 Ritter Pharmaceuticals, Inc. Methods and compositions for treating lactose intolerance
US20100316732A1 (en) * 2008-02-12 2010-12-16 Todd James Smith Beverage compositions for the promotion of joint health in companion animals
US8486668B2 (en) 2009-02-24 2013-07-16 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
US8785160B2 (en) 2009-02-24 2014-07-22 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
US9579340B2 (en) 2009-02-24 2017-02-28 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
US9592248B2 (en) 2009-02-24 2017-03-14 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
US8492124B2 (en) 2009-02-24 2013-07-23 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
US9775860B2 (en) 2009-02-24 2017-10-03 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
US9808481B2 (en) 2009-02-24 2017-11-07 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
US20110236480A1 (en) * 2009-02-24 2011-09-29 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
US20100215738A1 (en) * 2009-02-24 2010-08-26 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
US9149056B2 (en) 2011-01-14 2015-10-06 The Iams Company Compositions and methods relating to carotenoids
CN106470555A (en) * 2014-06-18 2017-03-01 尤妮佳股份有限公司 Pet food plastochondria and pet food
US20170143005A1 (en) * 2014-06-18 2017-05-25 Unicharm Corporation Granular material for pet food and pet food

Also Published As

Publication number Publication date
EP1689247B1 (en) 2013-04-17
WO2005053425A1 (en) 2005-06-16
US10681922B2 (en) 2020-06-16
AR046743A1 (en) 2005-12-21
US20170027191A1 (en) 2017-02-02
EP1689247A1 (en) 2006-08-16
AU2004295003B2 (en) 2008-12-04
BRPI0417166A (en) 2007-03-06
JP2007512024A (en) 2007-05-17
CA2547330C (en) 2011-08-09
AU2004295003A1 (en) 2005-06-16
CA2547330A1 (en) 2005-06-16

Similar Documents

Publication Publication Date Title
US10681922B2 (en) Methods of enhancing the gastrointestinal health of a companion animal
JP2013126416A (en) Companion animal composition comprising short chain oligofructose
AU2008229785B2 (en) Methods and kits related to administration of a fructooligosaccharide
CN104206859B (en) Antibiotic-free feed for fattening pigs and preparation method thereof
US20090324761A1 (en) Methods And Compositions for Improving Gastrointestinal Health
CN108634118A (en) It is a kind of improve weanling pig intestinal health feed addictive and its preparation and application
Wang et al. Effects of grazing and confinement on the morphology and microflora of the gastrointestinal tract of Small-tailed Han sheep
CN107712356A (en) A kind of feed addictive and preparation method thereof, feed
Elliethy et al. Influence of prebiotic, probiotic and synbiotic supplementation on digestibility, haemobiochemical profile and productive performance in Barki lambs
Håkenåsen Feed intake, nutrient digestibility, growth performance and general health of piglets fed increasing levels of yeast
Linsart et al. Palatability and digestive tolerance of a new high protein/low carbohydrate commercial dry diet in adult ferrets
Samsudin et al. Effect of Probiotics in Different Ration Proteins on Protein Consumption in 10-Week-Old Native Chicken
Carros et al. Efficacy and tolerance of two low-carbohydrate diets in large adult dogs with digestive sensitivity: a randomized, cross-over, blinded evaluation
US20220322702A1 (en) Seaweed blend feed supplement
Paschoalin de Souza Nogueira Dietary supplementation of a fiber-prebiotic-gut health promoter blend in extruded diets fed to dogs
Sattar et al. Effects of Probiotic and Organic Acids with Yeast Extract on Body Weight Gain and Hemato-Biochemical Parameters in Broilers
CN109601709A (en) A kind of feed addictive, preparation method and application improving animal immune performance
JO et al. Evaluation of the effect of feeding commercial synbiotic and diet-acidifiers on histological and gut morphometric of Arbor-Acre broiler chickens
Verstegen Natural animal health products (NAHP): opportunities for NAHP, plant bioactives and animal health. The European experience.
Leib Dietary Management of Diarrhea

Legal Events

Date Code Title Description
AS Assignment

Owner name: PROCTER & GAMBLE COMPANY, THE, OHIO

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:NORTON, SHARON ANN;GOLDY, GARY GREGORY;REEL/FRAME:014525/0993;SIGNING DATES FROM 20031210 TO 20031215

AS Assignment

Owner name: PROCTER & GAMBLE COMPANY, THE, OHIO

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:NORTON, SHARON ANN;GOLDY, GARY GREGORY;REEL/FRAME:014531/0937;SIGNING DATES FROM 20031210 TO 20031215

AS Assignment

Owner name: THE IAMS COMPANY, OHIO

Free format text: CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE TO THE IAMS COMPANY PREVIOUSLY RECORDED ON REEL 014531 FRAME 0937. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT;ASSIGNORS:NORTON, SHARON ANN;GOLDY, GARY GREGORY;SIGNING DATES FROM 20031210 TO 20031215;REEL/FRAME:031831/0657

AS Assignment

Owner name: MARS, INCORPORATED, VIRGINIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:THE IAMS COMPANY;REEL/FRAME:037197/0153

Effective date: 20151027

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION